Use of Pembrolizumab in tumor-agnostic MSI-high patients

Use of Pembrolizumab in tumor-agnostic MSI-high patients

User Photo
obr

3 years
434 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Richard M. Goldberg, MD, FAnnual Meeting of West Virginia University Cancer Institute discusses the use of pembrolizumab in tumor-agnostic MSI-high patients at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Up Next Autoplay
>